Home9LB • FRA
add
Legend Biotech Corp
Previous close
€30.60
Year range
€29.80 - €64.50
Market cap
5.80B USD
Avg Volume
14.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 160.20M | 66.86% |
Operating expense | 79.57M | 61.72% |
Net income | -125.32M | -101.46% |
Net profit margin | -78.23 | -20.74% |
Earnings per share | -0.68 | -100.00% |
EBITDA | -67.98M | 24.34% |
Effective tax rate | -3.67% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.21B | -14.85% |
Total assets | 1.74B | -5.63% |
Total liabilities | 619.72M | 24.02% |
Total equity | 1.12B | — |
Shares outstanding | 183.45M | — |
Price to book | 5.03 | — |
Return on assets | -9.95% | — |
Return on capital | -11.88% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -125.32M | -101.46% |
Cash from operations | -75.82M | -24.61% |
Cash from investing | 329.08M | 257.40% |
Cash from financing | 4.24M | 341.73% |
Net change in cash | 258.02M | 195.66% |
Free cash flow | -69.63M | 1.26% |
About
Founded
2014
Headquarters
Website
Employees
2,400
